Monday, September 29, 2025

Top Undervalued Dividend Growth Stocks and Funds to Buy Now (September 2025)

 Top Undervalued Dividend Growth Stocks and Funds to Buy Now (September 2025)

As of late September 2025, dividend growth stocks and funds remain attractive amid market volatility, offering reliable income with potential for capital appreciation. These selections focus on companies and ETFs with histories of consistent dividend increases (e.g., Dividend Aristocrats with 25+ years), strong fundamentals, and current discounts to fair value estimates (15%+ undervaluation based on analyst models like Morningstar's). Yields are approximate and fluctuate; data draws from recent analyst consensus. Prioritize diversification across sectors and consult a financial advisor.Top Undervalued Dividend Growth StocksThese 8 picks emphasize Dividend Aristocrats/Kings where possible, with sustainable payout ratios (<70%), projected 5%+ annual dividend growth, and resilience in staples, healthcare, and telecom. They're trading below historical P/E averages or fair values due to temporary headwinds like tariffs or sector softness.
Stock Ticker
Company Name
Sector
Current Yield
Years of Dividend Growth
Why Undervalued & Growing Now?
MRK
Merck & Co.
Healthcare
3.2%
13
24% below $111 fair value on HPV vaccine softness in China; ~50% payout supports 5-7% annual hikes; Keytruda pipeline drives 8% EPS growth.
PEP
PepsiCo
Consumer Staples
3.5%
52 (Aristocrat)
11% discount to $162 fair value, P/E 25.8x (vs. 28x historical); mid-single-digit growth via resilient brands; 66% payout ratio.
VZ
Verizon Communications
Telecom
6.5%
19
20% undervalued at 8.5x forward P/E; stable wireless cash flows; 2-3% growth from Frontier synergies, 50% coverage.
UPS
United Parcel Service
Industrials
6.5%
15
15% below fair value post-wage pressures; e-commerce rebound projects 5%+ revenue growth; payout to 60% by 2026.
KMB
Kimberly-Clark
Consumer Staples
3.8%
53 (Aristocrat)
20% undervalued on volume dips; fiscal 2025 gains from Huggies investments; 5%+ history, <60% payout.
CLX
Clorox
Consumer Staples
3.9%
47 (Aristocrat)
26% below $177 fair value amid sales stabilization; mid-single-digit growth, ~60% payout; tariff mitigation via efficiencies.
O
Realty Income
Real Estate (REIT)
5.3%
30 (Aristocrat)
Discount to NAV; 4.2% CAGR since 1994, 663 monthly payouts; 3-5% growth from diversified retail amid rate cuts.
SYY
Sysco
Consumer Staples
2.8%
55 (Aristocrat)
17% market share in $370B industry; 3-5% sales growth FY2026; recent $0.03 hike, strong balance sheet.
Top Undervalued Dividend Growth Funds (ETFs)For easier diversification, these ETFs track dividend growers (10+ years of increases) and trade at discounts to NAV or peers. They offer low fees (under 0.35%), monthly/quarterly payouts, and exposure to 200+ holdings. Focus on those with quality/momentum tilts for sustainability.
ETF Ticker
Fund Name
Expense Ratio
Current Yield
Why Undervalued & Growing Now?
SCHD
Schwab U.S. Dividend Equity ETF
0.06%
3.6%
Tracks Dow Jones U.S. Dividend 100 Index; 90% in stable sectors; outperformed peers YTD, 10%+ 5-yr ann. return; undervalued vs. broad market.
VIG
Vanguard Dividend Appreciation ETF
0.06%
1.8%
Targets 10+ yrs growth; top holdings like MSFT, AVGO; long-term focus beats high-yield peers; 12% discount to growth ETFs.
DGRO
iShares Core Dividend Growth ETF
0.08%
2.3%
5+ yrs increases, quality screen; loaded with aristocrats; monthly income option, downside protection; 8% below fair value.
NOBL
ProShares S&P 500 Dividend Aristocrats ETF
0.35%
2.0%
Exclusive 25+ yr aristocrats (69 holdings); beat SPY in Aug 2025; undervalued with 5.19% avg. growth rate.
FDVV
Fidelity High Dividend ETF
0.15%
3.1%
Large/mid-cap focus, payout/growth screens; monthly dividends; strong in financials/energy; 15% discount post-volatility.
Key Insights:
  • Why These? Stocks average 3-6% yields with 4-7% projected growth; funds provide instant diversification (e.g., SCHD's 100 holdings). All show undervaluation via P/E, DCF models, or NAV discounts, per Morningstar/Seeking Alpha.
  • Growth Outlook: Aristocrats' 5.55% avg. hike in 2025 supports compounding; staples/healthcare resist recessions.
  • Risks: Interest rate shifts could hit REITs/telecom; monitor Q3 earnings for coverage.
  • Strategy Tip: Allocate 20-30% to funds for core exposure, add 2-3 stocks for tilt. Reinvest dividends for 8-10% total returns over 5 years.
These are consensus "buy now" picks before year-end rallies. Verify latest prices on platforms like Yahoo Finance.